Von Rickenbach Josef H's Form 4 filing
Rein Therapeutics, Inc. (RNTX) · filed May 28, 2026
- Accession no.
- 0001193125-26-245832
- Filed
- May 28, 2026
- Trade date
- May 21-27, 2026
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $49.7K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Von Rickenbach Josef HCIK 0001007706 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | Common stock , $0.001 par value | PPurchaseAcquired | +3,420 | $1.04 | +$3,556.8 | 18,874 | Direct | |
| May 22, 2026 | Common stock , $0.001 par value | PPurchaseAcquired | +15,950 | $1.05 | +$16,747.5 | 34,824 | Direct | |
| May 26, 2026 | Common stock , $0.001 par value | PPurchaseAcquired | +23,190 | $1.06 | +$24,581.4 | 58,014 | Direct | |
| May 27, 2026 | Common stock , $0.001 par value | PPurchaseAcquired | +4,500 | $1.07 | +$4,815 | 62,514 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.